GBA1 and Parkinson disease: Indeed, heterozygotes for GBA1 mutations occur with greater frequency in patients afflicted with Parkinson's disease [45] and there is a pathogenic relationship between GCase alterations, mitochondrial dysfunction, and Parkinson's disease [41], [46]–[48].